Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the ...
On Feb. 5, Aurora Cannabis reported its fiscal third-quarter results for the period ended Dec. 31. The cannabis company ...
Shares of Aurora Cannabis Inc. ACB shed 4.68% to $6.31 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.41% to ...
Operator Greetings, and welcome to the Aurora Cannabis Inc. third quarter 2025 results conference call. [Operator ...
Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...
CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical ...
ACB Agreement Complements Existing Relationship Focused on the Supply of Premium CannabisEDMONTON, AB, February 6, 2 ...
Aurora Cannabis has a 12-month low of $2.84 and a 12-month high of $9.35. The business’s 50-day moving average is $4.35 and its 200 day moving average is $5.16.
Greetings and welcome to the Aurora Cannabis Inc. Third Quarter 2025 Results Conference Call. All participants will be in a listen-only mode and a question-and-answer session will follow the formal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback